Curcumin-induced heme oxygenase-1 expression prevents H2O2-induced cell death in wild type and heme oxygenase-2 knockout adipose-derived mesenchymal stem cells.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Apoptosis/*drug effects ; Curcumin/*pharmacology ; Heme Oxygenase (Decyclizing)/*genetics ; Heme Oxygenase-1/*metabolism ; Hydrogen Peroxide/*toxicity; Acetylcysteine/pharmacology ; Adipose Tissue/cytology ; Animals ; Antioxidants/pharmacology ; Bilirubin/pharmacology ; Biliverdine/pharmacology ; Cells, Cultured ; Heme Oxygenase (Decyclizing)/deficiency ; Heme Oxygenase (Decyclizing)/metabolism ; Heme Oxygenase-1/genetics ; Mesenchymal Stem Cells/cytology ; Mesenchymal Stem Cells/drug effects ; Mesenchymal Stem Cells/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Organometallic Compounds/pharmacology ; RNA, Messenger/metabolism ; Up-Regulation/drug effects

Mesenchymal stem cell (MSC) administration is a promising adjuvant therapy to treat tissue injury. However, MSC survival after administration is often hampered by oxidative stress at the site of injury. Heme oxygenase (HO) generates the cytoprotective effector molecules biliverdin/bilirubin, carbon monoxide (CO) and iron/ferritin by breaking down heme. Since HO-activity mediates anti-apoptotic, anti-inflammatory, and anti-oxidative effects, we hypothesized that modulation of the HO-system affects MSC survival. Adipose-derived MSCs (ASCs) from wild type (WT) and HO-2 knockout (KO) mice were isolated and characterized with respect to ASC marker expression. In order to analyze potential modulatory effects of the HO-system on ASC survival, WT and HO-2 KO ASCs were pre-treated with HO-activity modulators, or downstream effector molecules biliverdin, bilirubin, and CO before co-exposure of ASCs to a toxic dose of H2O2. Surprisingly, sensitivity to H2O2-mediated cell death was similar in WT and HO-2 KO ASCs. However, pre-induction of HO-1 expression using curcumin increased ASC survival after H2O2 exposure in both WT and HO-2 KO ASCs. Simultaneous inhibition of HO-activity resulted in loss of curcumin-mediated protection. Co-treatment with glutathione precursor N-Acetylcysteine promoted ASC survival. However, co-incubation with HO-effector molecules bilirubin and biliverdin did not rescue from H2O2-mediated cell death, whereas co-exposure to CO-releasing molecules-2 (CORM-2) significantly increased cell survival, independently from HO-2 expression. Summarizing, our results show that curcumin protects via an HO-1 dependent mechanism against H2O2-mediated apoptosis, and likely through the generation of CO. HO-1 pre-induction or administration of CORMs may thus form an attractive strategy to improve MSC therapy.

Phytother Res. 2012 Jul;26(7):988-94. (PMID: 22144097)
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10925-30. (PMID: 9380736)
Cell Biol Int. 2008 Oct;32(10):1256-64. (PMID: 18692581)
Eur J Cardiothorac Surg. 2008 Oct;34(4):850-6. (PMID: 18640847)
Bioorg Med Chem Lett. 2005 Mar 1;15(5):1457-61. (PMID: 15713406)
J Am Coll Cardiol. 2005 Oct 4;46(7):1339-50. (PMID: 16198853)
J Lipid Res. 2012 Feb;53(2):227-46. (PMID: 22140268)
Am J Physiol Cell Physiol. 2006 May;290(5):C1399-410. (PMID: 16371440)
J Cell Biochem. 2013 May;114(5):1163-73. (PMID: 23192437)
Biomed Pharmacother. 2011 Aug;65(5):369-74. (PMID: 21775089)
Basic Res Cardiol. 2010 May;105(3):431-42. (PMID: 20033189)
Circ Res. 2007 Oct 26;101(9):862-4. (PMID: 17967796)
Tohoku J Exp Med. 2012;226(3):231-41. (PMID: 22450704)
Free Radic Biol Med. 2003 Oct 15;35(8):872-81. (PMID: 14556851)
Neuroscience. 2000;99(4):587-92. (PMID: 10974422)
Am J Physiol. 1997 Jul;273(1 Pt 1):G7-17. (PMID: 9252504)
Curr Pharm Des. 2013;19(15):2698-707. (PMID: 23092328)
Inflammation. 2013 Jun;36(3):651-7. (PMID: 23250825)
Respirology. 2013 Apr;18(3):397-411. (PMID: 23316733)
Wound Repair Regen. 2006 May-Jun;14(3):325-35. (PMID: 16808812)
Cell Stress Chaperones. 2012 Sep;17(5):553-65. (PMID: 22362068)
PLoS One. 2012;7(8):e43180. (PMID: 22905226)
Biomaterials. 2012 Jul;33(21):5177-86. (PMID: 22534037)
Cell Stem Cell. 2011 Jul 8;9(1):11-5. (PMID: 21726829)
Biochim Biophys Acta. 2007 Jul;1773(7):1073-86. (PMID: 17532486)
Circ Res. 2009 Feb 27;104(4):506-13. (PMID: 19122175)
Adv Exp Med Biol. 2007;595:1-75. (PMID: 17569205)
Biomaterials. 2011 Apr;32(12):3189-209. (PMID: 21300401)
Pediatr Res. 2012 Apr;71(4 Pt 2):491-9. (PMID: 22430385)
Front Immunol. 2012 Jul 10;3:192. (PMID: 22787462)
J Surg Res. 2011 Mar;166(1):138-45. (PMID: 20828719)
Stem Cell Res Ther. 2011 Mar 07;2(2):12. (PMID: 21385372)
Stem Cells. 2012 May;30(5):804-10. (PMID: 22415904)
Oxid Med Cell Longev. 2012;2012:794237. (PMID: 22928087)
Stem Cells. 2011 Jan;29(1):99-107. (PMID: 20957739)
Annu Rev Pharmacol Toxicol. 2010;50:323-54. (PMID: 20055707)
Lung Cancer. 2008 Apr;60(1):1-3. (PMID: 18063196)
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2445-50. (PMID: 10051662)
Neurobiol Dis. 2012 Jun;46(3):635-45. (PMID: 22426403)
Biotechnol Adv. 2014 Nov 1;32(6):1053-64. (PMID: 24793420)
Cell Stress Chaperones. 2012 Mar;17(2):181-90. (PMID: 21993906)
Biochemistry. 2007 Feb 20;46(7):1860-7. (PMID: 17253780)
J Med Chem. 2008 Oct 9;51(19):5943-52. (PMID: 18798608)
Free Radic Biol Med. 2000 Apr 15;28(8):1303-12. (PMID: 10889462)
J Investig Dermatol Symp Proc. 2011 Dec;15(1):48-52. (PMID: 22076327)
Stem Cells Transl Med. 2013 Jan;2(1):33-42. (PMID: 23283490)
Stem Cells. 2006 Feb;24(2):416-25. (PMID: 16253984)
Curr Neurovasc Res. 2005 Apr;2(2):121-31. (PMID: 16181104)
Br J Pharmacol. 2000 May;130(1):57-64. (PMID: 10780998)
Tissue Eng. 2006 Jul;12(7):1891-901. (PMID: 16889519)
Cell Mol Life Sci. 2008 Jun;65(11):1631-52. (PMID: 18324353)
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5171-6. (PMID: 19286972)
Biochem Pharmacol. 2003 Oct 1;66(7):1287-95. (PMID: 14505808)
J Cell Biochem. 2010 Nov 1;111(4):967-78. (PMID: 20665666)
Arthritis Rheum. 2012 Nov;64(11):3604-13. (PMID: 22961401)
J Immunol. 2008 Feb 15;180(4):2581-7. (PMID: 18250469)
BMB Rep. 2008 Feb 29;41(2):164-9. (PMID: 18315954)
Planta Med. 2002 May;68(5):445-8. (PMID: 12058323)
Apoptosis. 2011 May;16(5):468-77. (PMID: 21373935)
J Burn Care Res. 2010 Nov-Dec;31(6):874-81. (PMID: 20859216)
Curr Opin Pediatr. 2012 Jun;24(3):371-8. (PMID: 22572760)
Biomed Pharmacother. 2012 Feb;66(1):57-63. (PMID: 22281292)
Stem Cells Transl Med. 2012 Feb;1(2):142-9. (PMID: 23197761)
Transplant Rev (Orlando). 2012 Apr;26(2):125-39. (PMID: 22000659)
Pharmacol Rev. 2008 Mar;60(1):79-127. (PMID: 18323402)
Exp Lung Res. 2010 Aug;36(6):352-61. (PMID: 20653470)
Transplant Proc. 2008 Oct;40(8):2649-54. (PMID: 18929828)
J Pharmacol Exp Ther. 2009 Dec;331(3):906-16. (PMID: 19717790)
Curr Drug Targets. 2010 Dec;11(12):1571-85. (PMID: 20704545)
J Pharmacol Exp Ther. 2009 Dec;331(3):925-32. (PMID: 19773531)
J Dermatol Sci. 2007 Oct;48(1):43-52. (PMID: 17644316)
Tohoku J Exp Med. 2012;226(1):29-36. (PMID: 22186034)
Thromb Haemost. 2012 Sep;108(3):464-75. (PMID: 22872040)
Stem Cells Dev. 2012 Jul 1;21(10):1675-87. (PMID: 22034921)
Br J Pharmacol. 2006 Feb;147(3):307-15. (PMID: 16331285)
J Mol Med (Berl). 2008 Mar;86(3):267-79. (PMID: 18034222)
Free Radic Biol Med. 2008 Sep 1;45(5):562-9. (PMID: 18549826)
Oxid Med Cell Longev. 2014;2014:960362. (PMID: 24683439)
Arthritis Res Ther. 2007;9(1):204. (PMID: 17316462)
PLoS One. 2012;7(4):e34994. (PMID: 22514698)
Aesthetic Plast Surg. 2012 Oct;36(5):1260-5. (PMID: 22936379)
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2542-7. (PMID: 16224047)
Neuroscience. 2013 Sep 17;248:333-43. (PMID: 23727509)
Immune Netw. 2011 Dec;11(6):376-82. (PMID: 22346778)
Cell Res. 2002 Jun;12(2):123-32. (PMID: 12118938)
J Cell Biochem. 2009 Apr 15;106(6):984-91. (PMID: 19229871)
J Biomed Sci. 2010 Oct 07;17:80. (PMID: 20925964)
J Cell Biochem. 2013 Oct;114(10):2346-55. (PMID: 23824714)
Am J Respir Crit Care Med. 2005 Sep 15;172(6):660-70. (PMID: 15901614)
Diabetes Res Clin Pract. 2013 Jun;100(3):368-75. (PMID: 23618552)
Arch Biochem Biophys. 2009 Dec;492(1-2):74-81. (PMID: 19772854)
Int J Clin Exp Med. 2010 Sep 07;3(4):248-69. (PMID: 21072260)
Am J Respir Cell Mol Biol. 2011 Oct;45(4):867-73. (PMID: 21441382)
Biomaterials. 2013 Jan;34(1):112-20. (PMID: 23059006)
Antioxid Redox Signal. 2014 Apr 10;20(11):1754-69. (PMID: 24124891)
Transplantation. 2003 Feb 15;75(3):389-97. (PMID: 12589164)
Stem Cells Transl Med. 2013 Dec;2(12):1011-9. (PMID: 24167320)
Mediators Inflamm. 2014;2014:279171. (PMID: 24616552)
Mol Biol Cell. 2010 Jun 1;21(11):1783-7. (PMID: 20375149)
J Neurochem. 2003 Jun;85(5):1247-61. (PMID: 12753084)
Curr Drug Targets. 2011 Mar 1;12(3):332-47. (PMID: 20955148)
Br J Nutr. 2010 Jun;103(11):1545-57. (PMID: 20100380)
Biofactors. 1998;8(1-2):7-11. (PMID: 9699001)
Cell Physiol Biochem. 2012;29(1-2):99-110. (PMID: 22415079)
Biochem Pharmacol. 2007 Nov 1;74(9):1361-70. (PMID: 17719563)
J Cell Mol Med. 2009 Apr;13(4):712-25. (PMID: 18410527)
Cell Stress Chaperones. 2013 Nov;18(6):785-800. (PMID: 23620204)
Am J Physiol Cell Physiol. 2006 Nov;291(5):C897-908. (PMID: 16822952)
Biochem Biophys Res Commun. 2004 May 21;318(1):88-94. (PMID: 15110757)
J Transl Med. 2012 Dec 05;10:243. (PMID: 23217165)
Mitochondrion. 2007 Dec;7(6):367-73. (PMID: 17855174)
Biochem Biophys Res Commun. 2006 May 12;343(3):965-72. (PMID: 16574070)
Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1320-9. (PMID: 20154257)
Biochim Biophys Acta. 2013 Aug;1830(8):4117-29. (PMID: 23618697)

R01 NS079500 United States NS NINDS NIH HHS

0 (Antioxidants)
0 (Organometallic Compounds)
0 (RNA, Messenger)
0 (tricarbonyldichlororuthenium (II) dimer)
BBX060AN9V (Hydrogen Peroxide)
EC 1.14.14.18 (Heme Oxygenase (Decyclizing))
EC 1.14.14.18 (Heme Oxygenase-1)
EC 1.14.14.18 (heme oxygenase-2)
IT942ZTH98 (Curcumin)
O9MIA842K9 (Biliverdine)
RFM9X3LJ49 (Bilirubin)
WYQ7N0BPYC (Acetylcysteine)

Date Created: 20141010 Date Completed: 20150603 Latest Revision: 20211021

20250114

PMC4227200

10.3390/ijms151017974

25299695